|
Published by: Millennium Research
Published: May. 10, 2007
Table of Contents
- EXECUTIVE SUMMARY
- METHODOLOGY
- 1.0 HYALURONIC ACID VISCOSUPPLEMENTATION BACKGROUND
- 1.1 Osteoarthritis and Rheumatoid Arthritis
- 1.1.1 Osteoarthritis Overview
- 1.1.2 Rheumatoid Arthritis Overview
- 1.2 Hyaluronic Acid Viscosupplementation Overview
- 2.0 GLOBAL OVERVIEW
- 2.1 Market Overview
- 2.2 Global Competitive Analysis
- 3.0 US HA VISCOSUPPLEMENTATION MARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Procedures
- 3.2.1.1 Total Injection Volumes
- 3.2.1.2 Total Treatment Volumes
- 3.2.2 Indications
- 3.2.3 Market Forecast
- 3.2.4 Market Drivers and Limiters
- 3.2.4.1 Market Drivers
- 3.2.4.2 Market Limiters
- 3.3 Competitive Analysis
- 3.3.1 Emerging Competitors
- 4.0 JAPANESE HA VISCOSUPPLEMENTATION MARKET
- 4.1 Market Overview
- 4.2 Market Analysis
- 4.2.1 Procedures
- 4.2.2 Market Forecast
- 4.2.3 Market Drivers and Limiters
- 4.2.3.1 Market Drivers
- 4.2.3.2 Market Limiters
- 4.2.3.3 Market Trends
- 4.3 Competitive Analysis
- 4.3.1 Emerging Competitors
- 5.0 EUROPEAN HA VISCOSUPPLEMENTATION MARKET
- 5.1 Market Overview
- 5.2 Market Analysis
- 5.2.1 Procedures
- 5.2.1.1 Austrian HA Viscosupplementation Procedures
- 5.2.1.2 French HA Viscosupplementation Procedures
- 5.2.1.3 German HA Viscosupplementation Procedures
- 5.2.1.4 Italian HA Viscosupplementation Procedures
- 5.2.1.5 Spanish HA Viscosupplementation Procedures
- 5.2.1.6 UK HA Viscosupplementation Procedures
- 5.2.2 Market Forecast
- 5.2.2.1 Austrian HA Viscosupplementation Market Forecast
- 5.2.2.2 French HA Viscosupplementation Market Forecast
- 5.2.2.3 German HA Viscosupplementation Market Forecast
- 5.2.2.4 Italian HA Viscosupplementation Market Forecast
- 5.2.2.5 Spanish HA Viscosupplementation Market Forecast
- 5.2.2.6 UK HA Viscosupplementation Market Forecast
- 5.2.3 Market Drivers and Limiters
- 5.2.3.1 Market Drivers
- 5.2.3.2 Market Limiters
- 5.3 Competitive Analysis
- APPENDIX A: MRG ACRONYMS AND INITIALISMS
- MRG List of Exhibits
- EXECUTIVE SUMMARY
- Exhibit ES-1: HA Viscosupplementation Market, by Region, Global (US$),2005-2011
- Exhibit ES-2: HA Treatment ASP, US (US$), 2005-2011
- Exhibit ES-3: HA Injections, Japan, 2006 and 2011
- Exhibit ES-4: 1-Injection HA Viscosupplementation Treatments, Europe,E2005-2011
- Exhibit ES-5: Leading Competitors in the HA Viscosupplementation Market,Global, 2006
- METHODOLOGY
- Exhibit M-1: Currency Exchange Rates, 2006
- CHAPTER 2: GLOBAL HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- Exhibit 2-1: HA Viscosupplementation Market, by Region, Global (US$),2005-2011
- Exhibit 2-2: HA Viscosupplementation Treatment Volumes, by Region,Global, 2005-2011
- Exhibit 2-3: HA Viscosupplementation Market, By Region, (US$), Global,2005-2011
- Exhibit 2-4: Leading Competitors in the HA Viscosupplementation Market,Global, 2006 (Graphical Format)
- Exhibit 2-5: Leading Competitors in the HA Viscosupplementation Market,Global, 2006 (Tabular Format)
- CHAPTER 3: US HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- Exhibit 3-1: HA Viscosupplementation Market, US (US$), 2005-2011
- Exhibit 3-2: HA Injection and Treatment Volumes, US, 2005-2011
- Exhibit 3-3: HA Injection Volumes, by Indication, US, 2005-2011
- Exhibit 3-4: HA Treatment Volumes, by Indication, US, 2005-2011
- Exhibit 3-5: HA Injection Volumes, by Indication, as a % of Total, US, 2005-2011
- Exhibit 3-6: HA Treatment Volumes, by Indication, as a % of Total, US,2005-2011
- Exhibit 3-7: HA Injection Market, US (US$), 2005-2011
- Exhibit 3-8: HA Treatment Market, by Indication, US (US$), 2005-2011
- Exhibit 3-9: Drivers and Limiters of the HA Viscosupplementation Market,US
- Exhibit 3-10: Leading Competitors in the HA Viscosupplementation Market,US, 2006
- CHAPTER 4: JAPANESE HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- Exhibit 4-1: HA Viscosupplementation Market, Japan (US$), 2005-2011
- Exhibit 4-2: HA Treatments and Injections, Japan, 2005-2011
- Exhibit 4-3: HA Injection Market, Japan (US$), 2005-2011
- Exhibit 4-4: HA Injection Market, Japan (¥), 2005-2011
- Exhibit 4-5: Drivers, Limiters, and Trends of the HA ViscosupplementationMarket, Japan
- Exhibit 4-6: Over-65 Cohort as a % of Total Population, Europe, Japan, andUS, 2005-2050
- Exhibit 4-7: Diagnosed Arthritis Sufferers, Japan, 2006
- Exhibit 4-8: Leading Competitors in the HA Viscosupplementation Market,Japan, 2006
- CHAPTER 5: EUROPEAN HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- Exhibit 5-1: HA Viscosupplementation Market, Europe (US$), 2005-2011
- Exhibit 5-2: HA Viscosupplementation Injections and Treatments, Europe,2006
- Exhibit 5-3: HA Viscosupplementation Injections and Treatments, Europe,2005-2011
- Exhibit 5-4: HA Viscosupplementation Injections, by Country, Europe, 2005-2011
- Exhibit 5-5: HA Viscosupplementation Injections and Treatments, Austria,2006
- Exhibit 5-6: HA Viscosupplementation Injections and Treatments, Austria,2005-2011
- Exhibit 5-7: HA Viscosupplementation Injections and Treatments, France,2006
- Exhibit 5-8: HA Viscosupplementation Injections andTreatments, France,2005-2011
- Exhibit 5-9: HA Viscosupplementation Injections and Treatments, Germany,2006
- Exhibit 5-10: HA Viscosupplementation Injections and Treatments,Germany, 2005-2011
- Exhibit 5-11: HA Viscosupplementation Injections and Treatments, Italy,2006
- Exhibit 5-12: HA Viscosupplementation Injections and Treatments, Italy,2005-2011
- Exhibit 5-13: HA Viscosupplementation Injections and Treatments, Spain,2006
- Exhibit 5-14: HA Viscosupplementation Injections and Treatments, Spain,2005-2011
- Exhibit 5-15: HA Viscosupplementation Injections and Treatments, UK, 2006
- Exhibit 5-16: HA Viscosupplementation Injections and Treatments, UK,2005-2011
- Exhibit 5-17: HA Viscosupplementation Injection Market, Europe (US$),2005-2011
- Exhibit 5-18: HA Viscosupplementation Injection Market, Europe (), 2005-2011
- Exhibit 5-19: HA Viscosupplementation Treatment Market, Europe (US$),2005-2011
- Exhibit 5-20: HA Viscosupplementation Treatment Market, Europe (),2005-2011
- Exhibit 5-21: HA Viscosupplementation Market, by Country, Europe (US$),2005-2011
- Exhibit 5-22: HA Viscosupplementation Market, by Country, Europe (),2005-2011
- Exhibit 5-23: HA Viscosupplementation Injection Market, Austria (US$),2005-2011
- Exhibit 5-24: HA Viscosupplementation Injection Market, Austria (), 2005-2011
- Exhibit 5-25: HA Viscosupplementation Treatment Market, Austria (US$),2005-2011
- Exhibit 5-26: HA Viscosupplementation Treatment Market, Austria (),2005-2011
- Exhibit 5-27: HA Viscosupplementation Injection Market, France (US$),2005-2011
- Exhibit 5-28: HA Viscosupplementation Injection Market, France (), 2005-2011
- Exhibit 5-29: HA Viscosupplementation Treatment Market, France (US$),2005-2011
- Exhibit 5-30: HA Viscosupplementation Treatment Market, France (), 2005-2011
- Exhibit 5-31: HA Viscosupplementation Injection Market, Germany (US$),2005-2011
- Exhibit 5-32: HA Viscosupplementation Injection Market, Germany (),2005-2011
- Exhibit 5-33: HA Viscosupplementation Treatment Market, Germany (US$),2005-2011
- Exhibit 5-34: HA Viscosupplementation Treatment Market, Germany (),2005-2011
- Exhibit 5-35: HA Viscosupplementation Injection Market, Italy (US$), 2005-2011
- Exhibit 5-36: A Viscosupplementation Injection Market, Italy (), 2005-2011
- Exhibit 5-37: HA Viscosupplementation Treatment Market, Italy (US$),2005-2011
- Exhibit 5-38: HA Viscosupplementation Treatment Market, Italy (), 2005-2011
- Exhibit 5-39: HA Viscosupplementation Injection Market, Spain (US$), 2005-2011
- Exhibit 5-40: HA Viscosupplementation Injection Market, Spain (), 2005-2011
- Exhibit 5-41: HA Viscosupplementation Treatment Market, Spain (US$),2005-2011
- Exhibit 5-42: HA Viscosupplementation Treatment Market, Spain (), 2005-2011
- Exhibit 5-43: HA Viscosupplementation Injection Market, UK (US$), 2005-2011
- Exhibit 5-44: HA Viscosupplementation Injection Market, UK (), 2005-2011
- Exhibit 5-45: HA Viscosupplementation Injection Market, UK (£), 2005-2011
- Exhibit 5-46: HA Viscosupplementation Treatment Market, UK (US$), 2005-2011
- Exhibit 5-47: HA Viscosupplementation Treatment Market, UK (), 2005-2011
- Exhibit 5-48: HA Viscosupplementation Treatment Market, UK (£), 2005-2011
- Exhibit 5-49: Drivers and Limiters of the HA Viscosupplementation Market,Europe
- Exhibit 5-50: Leading Competitors in the HA ViscosupplementationTreatment Market, by Country, Europe, 2006
AbstractThe global hyaluronic acid viscosupplementation market generated more than $900 million in 2006.
This market comprises the US, Japan, Austria, France, Germany, Italy, Spain, and the UK.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|